自然美(00157.HK)預期年度純利下跌84.5%
格隆匯1月28日丨自然美(00157.HK)發佈公吿,公司預期收入由上年度的4.38億港元下跌至2020年度的4.1億港元(即下跌6.4%)。集團收入下跌主要由於集團於中國的收入大幅下跌,乃因受COVID-19疫情影響,集團許多中國加盟店暫停營業所致。
預期集團毛利由2019年度的2.66億港元下跌至2020年度的2.41億港元(即下跌9.3%);及預期純利由2019年度的2190萬港元下跌至2020年度的340萬港元(即下跌84.5%)。集團純利下跌主要由於集團的毛利下跌;及集團的行政開支增加,預期由2019年度的7250萬港元上升至2020年度的8510萬港元(即上升17.4%),乃因公司申請恢復股份買賣所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.